Maria Veiga-da-Cunha, Claudia Soler-Alfonso and Sarah Grünert join the podcast to talk about Empagliflozin, a repurposed drug with impressive efficacy in GSD 1b and G6PC3 deficiency.
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5
Cécile Boulanger, et al
https://doi.org/10.1002/jimd.12509
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
Eran Tallis, et al
https://doi.org/10.1002/jmd2.12304
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Sarah Catharina Grünert, et al
https://doi.org/10.1002/jmd2.12295
view more